| Description | 2-benzylsulfanyl-6-methoxy-4-methylquinazoline can be used as a TRPML modulator for the treatment of diseases associated with TRPML activity, such as lysosomal storage disease, muscular dystrophy, oxidative stress or reactive oxygen species (ROS)-related diseases and ageing. |
| molecular weight | 296.39 |
| Molecular formula | C17H16N2OS |
| CAS | 500272-00-4 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
| Solubility | DMSO: 12 mg/mL (40.49 mM) |
| References | 1. Luan F, et al. TOPS-MODE model of multiplexing neuroprotective effects of drugs and experimental-theoretic study of new 1,3-rasagiline derivatives potentially useful in neurodegenerative diseases. Bioorg Med Chem. 2013 ; 21(7):1870-1879. |
2-benzylsulfanyl-6-methoxy-4-methylquinazoline
CAS No.: 500272-00-4
2-benzylsulfanyl-6-methoxy-4-methylquinazoline can be used as a TRPML modulator for the treatment of diseases associated
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.